Search





Search





Markets
/
Stocks
/
immx
/

Immix Biopharma Inc

IMMX

Add to Watchlist

8.110USD

-0.210-2.52%

Close 07-31 16:00（ET）Quotes delayed by 15 min

429.93MMarket Cap

LossP/E TTM

Immix Biopharma Inc

8.110

-0.210-2.52%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

IMMX Cash Flow Statement

You can access the annual and quarterly cash flow statements of Immix Biopharma Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2020Q4

FY2020Q3

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-483.17%-9.83M

-647.16%-11.03M

-46.32%-5.91M

-1.02%-5.31M

55.97%-1.69M

44.87%-1.48M

-30.76%-4.04M

-49.52%-5.26M

-82.93%-3.83M

31.42%-2.68M

-111.06%-3.09M

-542.58%-3.52M

-39.95%-2.09M

-250.41%-3.90M

-2781.24%-1.46M

---547.07K

---1.49M

-800.98%-1.11M

29.23%-50.76K

--158.93K

---71.72K

Net income from continuing operations

-122.05%-10.09M

-122.11%-10.69M

-6.10%-7.59M

-50.31%-6.62M

14.79%-4.54M

6.66%-4.81M

-64.58%-7.15M

-22.45%-4.41M

-113.41%-5.33M

-35.67%-5.16M

-182.98%-4.34M

-130.24%-3.60M

-87.53%-2.50M

83.30%-3.80M

-280.66%-1.54M

---1.56M

---1.33M

-2872.31%-22.76M

-246.69%-403.26K

---765.58K

---116.32K

Operating gains losses

54.74%91.58K

26.07%52.11K

274.38%96.99K

140.77%58.49K

148.13%59.18K

1243.86%41.34K

1775.89%25.91K

4701.38%24.30K

4622.77%23.85K

443.46%3.08K

143.99%1.38K

32.11%506.00

-18.55%505.00

-8.71%566.00

--383.00

--620.00

6.71%620.00

6.90%620.00

--581.00

--580.00

Other non-cash items

--39.19K

--38.52K

85.12%37.87K

4.53%21.34K

----

--20.46K

--20.42K

--20.84K

----

-100.00%0.00

148.50%50.00K

--50.00K

--0.00

3748.28%22.13M

--20.12K

--575.00K

--0.00

Change in working capital

-124.37%-470.34K

-138.75%-1.00M

-54.34%1.07M

146.33%700.70K

259.31%1.93M

81.80%2.59M

353.88%2.35M

-313.98%-1.51M

610.34%537.10K

525.41%1.42M

467.25%518.55K

-140.61%-365.30K

133.10%75.61K

45.05%-334.75K

-152.31%-141.20K

--899.62K

---228.47K

-274.58%-609.16K

513.17%269.90K

--348.93K

--44.02K

-Change in receivables

-100.04%-725.00

105.51%12.38K

-68.54%21.56K

-77.16%21.98K

319.80%2.00M

51.76%-224.78K

118.03%68.54K

285.79%96.25K

-1162.73%-911.54K

-664.45%-465.93K

-1199.60%-380.24K

122.64%24.95K

-100.75%-72.19K

-135.73%-60.95K

-37.41%-29.26K

---110.22K

---35.96K

-18.34%170.60K

37.79%-21.29K

--208.92K

---34.23K

-Change in prepaid expenses

-173.70%-866.60K

-134.99%-191.35K

-82.34%50.57K

-14.02%170.67K

33.62%-316.62K

-47.20%546.84K

-35.90%286.41K

114.95%198.51K

-1009.12%-476.99K

215.26%1.04M

104.40%446.83K

-487.45%-1.33M

87.84%-43.01K

-79.77%-898.59K

2403.27%218.60K

--342.68K

---353.74K

-28480.16%-499.87K

-179.09%-9.49K

---1.75K

--12.00K

-Change in payables and accrued expense

67.06%432.21K

-134.67%-790.86K

-48.26%1.04M

129.04%524.19K

-86.56%258.72K

167.04%2.28M

342.69%2.00M

-292.53%-1.80M

908.74%1.92M

36.72%854.22K

236.73%451.96K

38.57%937.49K

18.57%190.81K

303.58%624.79K

-223.58%-330.54K

--676.56K

--160.93K

-360.63%-306.89K

521.90%267.47K

--117.75K

--43.01K

-Change in other current assets

----

--0.00

---20.42K

----

Cash from non-recurring investing activities

Cash from operating activities

-483.17%-9.83M

-647.16%-11.03M

-46.32%-5.91M

-1.02%-5.31M

55.97%-1.69M

44.87%-1.48M

-30.76%-4.04M

-49.52%-5.26M

-82.93%-3.83M

31.42%-2.68M

-111.06%-3.09M

-542.58%-3.52M

-39.95%-2.09M

-250.41%-3.90M

-2781.24%-1.46M

---547.07K

---1.49M

-800.98%-1.11M

29.23%-50.76K

--158.93K

---71.72K

Investing cash flow

Net cash from continuing investing activities

-52.02%32.49K

-67.44%165.13K

37.16%372.46K

31.48%127.63K

-77.57%67.71K

3748.76%507.15K

597.84%271.54K

--97.07K

--301.91K

--13.18K

--38.91K

----

--0.00

Capital expenditures

-52.02%32.49K

-67.44%165.13K

37.16%372.46K

31.48%127.63K

-77.57%67.71K

3748.76%507.15K

597.84%271.54K

--97.07K

--301.91K

--13.18K

--38.91K

----

--0.00

Net cash flow from disposal of fixed assets

-52.02%32.49K

-67.44%165.13K

37.16%372.46K

31.48%127.63K

-77.57%67.71K

3748.76%507.15K

597.84%271.54K

--97.07K

--301.91K

--13.18K

--38.91K

----

--0.00

Net cash flow from investment products

---4.77M

---6.48M

----

Net cash flow from other investing activities

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

-6989.98%-4.80M

-1210.46%-6.65M

-37.16%-372.46K

-31.48%-127.63K

77.57%-67.71K

-3748.76%-507.15K

-597.84%-271.54K

---97.07K

---301.91K

---13.18K

---38.91K

----

--0.00

Financing cash flow

Cash flow from continuous financing activities

---37.56K

--95.67M

--10.61M

--1.11M

----

-100.00%0.00

13311.62%15.95M

38.28%586.69K

--10.07M

4527.64%4.69M

-95.92%118.92K

-97.73%424.28K

100.00%0.00

---105.96K

--2.91M

--18.72M

---18.35K

--0.00

Net cash flow from debt Issuance/repayment

----

--0.00

100.00%0.00

----

--0.00

---50.00K

--0.00

Net cash flow from common stock issuance/repurchase

----

--95.51M

--10.77M

--1.10M

----

-100.00%0.00

5617.16%15.95M

1427.44%584.07K

--10.13M

8511.77%4.71M

-90.43%278.92K

-100.24%-44.00K

--0.00

---55.96K

--2.91M

--18.65M

----

Proceeds from stock option exercised by employees

--33.53K

--2.00

--516.00

--5.82K

----

-100.00%0.00

--0.00

--2.49K

--2.62K

----

Proceeds from issuance of warrants

----

--124.80K

----

Net cash flow from other financing activities

---71.09K

--29.76K

---166.75K

----

100.00%0.00

-100.00%1.00

---58.80K

---15.82K

---160.00K

559.34%468.28K

100.00%0.00

--0.00

--71.02K

---18.35K

--0.00

Net cash from non-recurrent financing activities

Net cash from financing activities

---37.56K

--95.67M

--10.61M

--1.11M

----

-100.00%0.00

13311.62%15.95M

38.28%586.69K

--10.07M

4527.64%4.69M

-95.92%118.92K

-97.73%424.28K

100.00%0.00

---105.96K

--2.91M

--18.72M

---18.35K

--0.00

Net cash flow

Beginning cash balance

431.21%93.93M

-19.01%15.95M

-51.46%11.64M

-45.70%15.92M

0.98%17.68M

0.55%19.69M

89.47%23.98M

155.77%29.32M

30.31%17.51M

15.76%19.58M

-31.24%12.65M

-39.86%11.46M

-23.85%13.44M

44423.02%16.92M

16538.50%18.40M

--19.06M

--17.64M

-79.79%37.99K

-56.46%110.60K

--188.03K

--254.01K

Current period cash flow changes

-733.60%-14.68M

3982.61%77.98M

200.58%4.31M

19.85%-4.28M

-114.91%-1.76M

3.10%-2.01M

-161.84%-4.28M

-548.92%-5.34M

698.36%11.81M

40.44%-2.07M

566.33%6.93M

280.83%1.19M

-239.36%-1.97M

-119.76%-3.48M

-1946.43%-1.49M

---658.33K

--1.42M

8570.80%17.61M

-10.04%-72.61K

--203.06K

---65.98K

Effect of exchange rate changes

-60.16%-12.81K

53.26%-11.74K

-189.50%-20.55K

395.39%44.14K

22.82%-8.00K

-180.31%-25.13K

295.07%22.96K

-36.97%8.91K

-1744.48%-10.37K

20028.66%31.29K

49.57%-11.77K

366.53%14.14K

79.35%-562.00

-125.28%-157.00

-567.27%-23.34K

---5.30K

---2.72K

-98.59%621.00

-160.92%-3.50K

--44.12K

--5.74K

Ending cash balance

397.77%79.25M

431.21%93.93M

-19.01%15.95M

-51.46%11.64M

-45.70%15.92M

0.98%17.68M

0.55%19.69M

89.47%23.98M

155.77%29.32M

30.31%17.51M

15.76%19.58M

-31.24%12.65M

-39.86%11.46M

-23.85%13.44M

44423.02%16.92M

--18.40M

--19.06M

4411.66%17.64M

-79.79%37.99K

--391.09K

--188.03K

Free cash flow

-462.49%-9.86M

-464.44%-11.19M

-45.75%-6.28M

-1.58%-5.44M

57.55%-1.75M

26.29%-1.98M

-37.82%-4.31M

---5.35M

---4.13M

31.08%-2.69M

-113.72%-3.13M

----

-250.41%-3.90M

-2781.24%-1.46M

---547.07K

---1.49M

-800.98%-1.11M

29.23%-50.76K

--158.93K

---71.72K

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Immix Biopharma Inc Generate?



Immix Biopharma Inc generated -23.93M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Immix Biopharma Inc's Operating Cash Flow Change Year Over Year?



Immix Biopharma Inc's operating cash flow increased by -63.96% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Immix Biopharma Inc Spend on Capital Expenditures?



Immix Biopharma Inc spent 732.92K on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Immix Biopharma Inc's Financing Cash Flow Changed?



Immix Biopharma Inc used 107.39M in financing activities in the latest quarter.

What is free cash flow and why does it matter for IMMX?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Immix Biopharma Inc’s free cash flow in the latest quarter?



Free cash flow was -24.66M reflecting a -56.37% change from the previous year.